Services

Our services are centred around intellectual property that can be registered. We protect innovation, design, and branding across all sectors of industry, and at all stages in the supply chain.

For each IP right we offer services covering strategic advice, pre-registration searches, registrations and renewals, oppositions and dispute resolution. We handle work throughout the world, working with local colleagues in over 100 countries.

Sectors

Our attorneys specialise in one or more sectors of industry, which enables them to provide quality advice with a commercial focus.

Our patent specialists have detailed understanding of the background technology, which ensures that your patent applications are prepared with the correct scope, reducing the likelihood of challenges from third parties and objections from the patent office.

They also advise whether other forms of protection would be more appropriate. Our brand specialists work with brand managers for leading brands and their advice is commercially focussed making sure that you get the best value from your budget.

24th Jun 2020

The End of (Interrupted) Days is Nigh

Because of the disruption caused by the Covid 19 pandemic, since 24 March 2020 the UK IPO has treated every day as an “interrupted day” as far as deadlines are concerned. This applies to UK applications and registrations for: patents, supplementary protection certificates, trade marks, designs. It also applies to deadlines in proceedings relating to these rights, such as oppositions and invalidity actions.

4th May 2020

European and UK Patent Office Responses to Coronavirus – and Service as Normal at Reddie & Grose

These past months have seen unprecedented global upheaval in view of the spread of the Coronavirus through Europe. Fortunately, the European Patent Office (EPO) and the UK Intellectual Property Office (UKIPO) have in place procedures to minimise the negative impacts on patent applicants and rights holders. We have been monitoring the situation closely and Pete Sadler provides the details.

9th Apr 2020

The Rise of Ocado: An Intellectual Property Success Story

rocery delivery service Ocado was forced to temporarily suspend parts of its online service last month due to coronavirus (Covid-19). The panic buying induced by the virus resulted in a tenfold increase demand.[1][2] However, even before this unprecedented surge Ocado has been steadily growing over recent years. A quick Google search shows the impressive growth of Ocado’s share price since its initial public offering. Investment in technology and intellectual property (IP) have played a major role in this growth.

7th Apr 2020

Call for rapid sanitising technology for ambulances

Do you have an innovative or novel approach to clean ambulances quicker to help combat COVID-19? The UK Government is asking for your help. Currently it can take up to 45 minutes to clean ambulances once they have transported a patient suspected of having COVID-19. Rapid sanitising technology solutions are required to enable ambulances to be effectively decontaminated faster, so that they can return to service as quickly as possible.

26th Mar 2020

The UK manufacturing sector responds to the call for ventilators

The COVID-19 pandemic has created a worldwide shortage of ventilators, and in the UK, the NHS is soon expected to require significantly more ventilators than are currently in circulation. As a result, on Monday 16th March, the UK government called for businesses to help make ventilators and ventilator components in an attempt to dramatically increase the number of ventilators available to the NHS in a matter of weeks. In response, both existing manufacturers of ventilators are increasing production and other manufacturing businesses are joining the effort.

11th Mar 2020

A fight against time: Coronavirus vs Biotechnology

At the time of writing, over one hundred and eighteen thousand cases of novel coronavirus (Covid-19) have been confirmed worldwide and this number is expected to rise significantly. In response to the outbreak, pharmaceutical companies and research organisations are racing to develop new vaccines and repurposing existing anti-viral drugs.

Register for notifications
Enter your email address here to receive our monthly bulletin of IP news and developments.
    Please read our privacy notice.
Saved Staff
Staff member

Remove all

Saved profiles
Call +44 (0)20 7242 0901
Call +44 (0)1223 360 350
Call +49 (0) 89 206054 267
Call +(00) 31 70 800 2162